Numerous clinical trials evaluate interventions across diverse medical fields, ranging from advanced oncological indications—such as platinum-resistant and recurrent small cell lung carcinoma—to infectious and inflammatory diseases, including sepsis, influenza, Crohn disease, chronic periodontitis, and vaginitis. Spanning Early Phase 1 through Phase 4, these studies are sponsored by academic institutions, government organizations, and research hospitals such as the Mayo Clinic, National Institute of Allergy and Infectious Diseases, and Fayoum University Hospital. The trials encompass various recruitment statuses, including recruiting, active not recruiting, completed, and terminated.
| NCT Number | Recruitment | Conditions | Sponsor/Collaborators | Start Date | Phases |
|---|---|---|---|---|---|
| NCT07315165 | RECRUITING | Allogeneic Hematopoietic Stem Cell Transplant (Allo-HSCT) |
University of Nebraska |
2026-07-22 | PHASE2 |
| NCT06655649 | SUSPENDED | Obstructive Sleep Apnea; Sleep |
Johns Hopkins University |
2025-01-29 | PHASE1 |
| NCT05446571 | RECRUITING | Pregnant Women; CMV Infected Fetuses |
Assistance Publique - Hôpitaux de Paris |
2023-10-20 | PHASE3 |
| NCT07687264 | NOT_YET_RECRUITING | PCOS (Polycystic Ovary Syndrome); Insulinemic Response; Overweight (BMI > 25) |
University of Zurich |
2026-08-01 | |
| NCT07275580 | NOT_YET_RECRUITING | Autoimmune Rheumatic Diseases; Tooth Extraction; Infection Prevention; Antibiotic Prophylaxis |
University of Sao Paulo General Hospital |
2026-08-20 | PHASE4 |
| NCT06769126 | RECRUITING | Extensive Stage Lung Small Cell Carcinoma; Lung Small Cell Carcinoma, A Subtype; Lung Small Cell Carcinoma, I Subtype; Lung Small Cell Carcinoma, N Subtype; Lung Small Cell Carcinoma, P Subtype |
SWOG Cancer Research Network |
2025-11-06 | PHASE2 |
| NCT05973097 | RECRUITING | Oral Lichen Planus |
Peking University Third Hospital |
2023-07-30 | |
| NCT02657785 | RECRUITING | Primary Central Nervous System Lymphoma |
Navy General Hospital, Beijing |
2010-09 | PHASE2; PHASE3 |
| NCT07589322 | RECRUITING | Obesity and Metabolic Syndrome |
Tri-Service General Hospital (TSGH) |
2026-03-31 | |
| NCT07795047 | NOT_YET_RECRUITING | Congenital Hyperinsulinism (CHI) |
Odense University Hospital |
2026-09 | |
| NCT06184659 | RECRUITING | Sepsis; Septic Shock |
Scandinavian Critical Care Trials Group |
2025-06-26 | PHASE4 |
| NCT05912621 | RECRUITING | Obesity; Overweight and Obesity; Overweight |
Stanford University |
2023-11-09 | PHASE2 |
| NCT07603050 | NOT_YET_RECRUITING | Gaucher Disease Type 3 |
Shanghai Vitalgen BioPharma Co., Ltd. |
2026-05-14 | PHASE1; PHASE2 |
| NCT05751668 | SUSPENDED | Anatomic Stage IV Breast Cancer AJCC v8; Chemotherapy-Induced Peripheral Neuropathy; Metastatic Breast Carcinoma |
Alliance for Clinical Trials in Oncology |
2023-11-02 | PHASE2 |
| NCT07483736 | NOT_YET_RECRUITING | C15.378 |
Versailles Hospital |
2026-03 | PHASE3 |
| NCT07480850 | ACTIVE_NOT_RECRUITING | Refractory Diffuse Large B-Cell Lymphoma (DLBCL) |
Cancer Institute and Hospital, Chinese Academy of Medical Sciences |
2026-01-01 | PHASE2 |
| NCT07437170 | ACTIVE_NOT_RECRUITING | Acute Myeloid Leukemia; Pediatric Acute Myeloid Leukemia; NUP98 Fusion-positive Acute Myeloid Leukemia |
The Children's Hospital of Zhejiang University School of Medicine |
2024-01-01 | PHASE2 |
| NCT07199218 | RECRUITING | Autism; Autism Spectrum Disorder |
Bazelet Nehushtan LtD. |
2025-10-05 | PHASE2 |
| NCT06673056 | ACTIVE_NOT_RECRUITING | Ataxia-Telangiectasia; Ataxia-Telangiectasia (A-T) |
IntraBio Inc |
2025-03-18 | PHASE3 |
| NCT06847399 | RECRUITING | Obesity and Overweight; Binge Eating Disorder |
Johns Hopkins University |
2025-09-17 | PHASE2 |
| NCT07453498 | RECRUITING | Total Hip Arthroplasty (THA) |
University College Hospital Galway |
2025-11-18 | |
| NCT06970262 | WITHDRAWN | Lung Infection; Microbial Colonization; Food Intolerance Syndromes |
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology |
2026-09-20 | |
| NCT07560592 | RECRUITING | Heart Failure |
Maya Guglin, MD |
2026-01-21 | |
| NCT06544655 | ACTIVE_NOT_RECRUITING | Advanced Solid Tumors |
Bristol-Myers Squibb |
2024-10-10 | PHASE1 |
| NCT07690293 | NOT_YET_RECRUITING | Cancer-related Fatigue |
China Medical University Hospital |
2026-08-01 | |
| NCT02698254 | ACTIVE_NOT_RECRUITING | Recurrent Brain Neoplasm |
M.D. Anderson Cancer Center |
2016-07-20 | |
| NCT06747871 | RECRUITING | Chronic Pain; Tobacco Use; Opioid Substitution Treatment |
Duke University |
2025-04-15 | |
| NCT06802627 | NOT_YET_RECRUITING | Lung Cancer; Lung Resection |
Universidade do Porto |
2025-03-01 | |
| NCT07703137 | ENROLLING_BY_INVITATION | Parkinson's Disease |
University of Oklahoma |
2026-08-10 | |
| NCT07711522 | NOT_YET_RECRUITING | Posterior Spinal Instrumentation Patients |
Istanbul Medipol University Hospital |
2026-08-01 | EARLY_PHASE1 |
| NCT05332301 | RECRUITING | Healthy Nutrition |
Kirsten Bell |
2022-10-04 | |
| NCT07412444 | RECRUITING | MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease; Overweight |
Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis |
2026-05-06 | |
| NCT06811324 | RECRUITING | Obesity Prevention; Sarcopenia in Elderly; Cardiovascular Function; GLP - 1; Weight Loss |
The University of Texas Health Science Center at San Antonio |
2026-04-01 | PHASE2 |
| NCT06126315 | RECRUITING | Amyotrophic Lateral Sclerosis |
Mario Negri Institute for Pharmacological Research |
2025-03-26 | PHASE2; PHASE3 |
| NCT04283513 | SUSPENDED | Hemorrhagic Fever |
U.S. Army Medical Research and Development Command |
2022-10-31 | PHASE2 |
| NCT07701473 | NOT_YET_RECRUITING | Alveolar Ridge Deficiency; Alveolar Bone Loss |
Cairo University |
2026-09-01 | |
| NCT05796193 | ACTIVE_NOT_RECRUITING | Malaria |
London School of Hygiene and Tropical Medicine |
2023-10-02 | |
| NCT06965296 | NOT_YET_RECRUITING | Nicotine Dependence, Cigarettes |
State University of New York at Buffalo |
2026-08-24 | |
| NCT07245771 | RECRUITING | Obesity &Amp; Overweight |
Ikaria Bioscience Pty Ltd |
2025-11-04 | PHASE1; PHASE2 |
| NCT06357247 | SUSPENDED | Stroke |
Virginia Commonwealth University |
2024-03-04 | |
| NCT06735599 | RECRUITING | Hypertension (Without Type 2 Diabetes Mellitus); High Blood Pressure; Male; Female; Adult; Cognition; Endothelial Function (Reactive Hyperemia); Oxidative Stress; Diet; Overweight; Body Composition Measurement; Gut Microbiome; Arterial Stiffness; Caucasian Whites; Inflammation; Microvascular Function |
Georgia State University |
2024-09-17 | |
| NCT04771416 | SUSPENDED | Leukodystrophy, Globoid Cell |
Gemma Biotherapeutics |
2022-02-24 | PHASE1; PHASE2 |
| NCT01804634 | RECRUITING | Refractory and/or Relapsed Metastatic Solid Tumors |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2013-03-27 | PHASE2 |
| NCT07186413 | ACTIVE_NOT_RECRUITING | Acne Vulgaris |
Galderma R&D |
2025-09-23 | PHASE3 |
| NCT07695961 | NOT_YET_RECRUITING | Nutrition; Health and Wellbeing; Aging; Time Restricted Eating; Bone Health |
University of Manouba |
2026-06-15 | |
| NCT06451055 | WITHDRAWN | Isolated Impaired Fasting Glucose |
Emory University |
2026-06-01 | |
| NCT06934707 | NOT_YET_RECRUITING | Type 1 Diabetes (T1D); Nutrition Therapy; Glycemic Control for Diabetes Mellitus |
Hospital de Clinicas de Porto Alegre |
2025-04-20 | |
| NCT07616700 | RECRUITING | IgA Nephropathy (IgAN) |
Haisco Pharmaceutical Group Co., Ltd. |
2025-08-25 | PHASE2 |
| NCT05669820 | RECRUITING | Glioblastoma |
Peter Siesjö |
2024-01-15 | PHASE2; PHASE3 |
| NCT07063095 | RECRUITING | Gram Negative Infections; Sepsis and Septic Shock |
Angela HUTTNER |
2025-08-25 | PHASE3 |
| NCT06295250 | RECRUITING | Depression; Economic Vulnerability; Anxiety; Culture Specific Symptoms |
University of Massachusetts, Worcester |
2024-03-01 | |
| NCT05226169 | RECRUITING | Advanced Gastric Carcinoma |
Asan Medical Center |
2022-04-29 | PHASE3 |
| NCT07665658 | RECRUITING | Attention Deficit Hyperactivity Disorder |
Khyber Medical University Peshawar |
2026-03-01 | |
| NCT03989414 | ACTIVE_NOT_RECRUITING | Multiple Myeloma |
Celgene |
2019-09-30 | PHASE1; PHASE2 |
| NCT05338190 | RECRUITING | Primary Immune Thrombocytopenia (ITP) |
Assistance Publique - Hôpitaux de Paris |
2022-11-14 | PHASE3 |
| NCT06452199 | RECRUITING | Healthy; Healthy Nutrition |
University of Aarhus |
2024-06-10 | |
| NCT04041310 | ACTIVE_NOT_RECRUITING | Solid Tumor, Adult |
Nouscom SRL |
2019-10-21 | PHASE1; PHASE2 |
| NCT07490288 | RECRUITING | AML |
Institute of Hematology & Blood Diseases Hospital, China |
2026-05-08 | |
| NCT06075914 | RECRUITING | Sleep Deprivation; Nutritional Intervention |
Ohio State University |
2023-05-01 | |
| NCT04607954 | ACTIVE_NOT_RECRUITING | Platinum-Resistant Lung Small Cell Carcinoma; Platinum-Sensitive Lung Small Cell Carcinoma; Recurrent Extensive Stage Lung Small Cell Carcinoma; Refractory Extensive Stage Lung Small Cell Carcinoma |
Mayo Clinic |
2020-12-04 | PHASE2 |
| NCT05672901 | RECRUITING | Genitourinary Syndrome of Menopause |
Stratpharma AG |
2023-04-04 | |
| NCT07302256 | RECRUITING | Influenza |
Shanghai Institute Of Biological Products |
2025-12-16 | PHASE1 |
| NCT07742826 | RECRUITING | Impacted Mandibular Third Molar Extraction; Impacted Lower Third Molar; Impacted Wisdom Tooth |
Final International University |
2024-09-03 | |
| NCT07058207 | RECRUITING | Obesity; Solid Neoplasm; Stage II-IV; Curative Treatment |
Institut d'Investigació Biomèdica de Bellvitge |
2025-07-22 | |
| NCT06049680 | RECRUITING | Malnutrition, Child; Malnutrition; Essential Fatty Acid Deficiency (EFAD); Parenteral Nutrition Associated Cholestasis |
Fresenius Kabi |
2024-10-28 | PHASE4 |
| NCT07476144 | ACTIVE_NOT_RECRUITING | Smoking Behaviors |
JT International SA |
2026-01-08 | PHASE1 |
| NCT07130513 | RECRUITING | Krill Oil; Muscle Function; Grip Strength; Long-Term Conditions; Omega 3 Fatty Acids |
University of Glasgow |
2025-08-18 | |
| NCT07008456 | RECRUITING | Obese With Comorbidities; Obese Patients (BMI ≥ 30 kg/m²) |
Aphaia Pharma US LLC |
2025-09-12 | PHASE2 |
| NCT07180446 | ACTIVE_NOT_RECRUITING | Obesity &Amp; Overweight |
Texas Christian University |
2026-01-18 | |
| NCT04662723 | RECRUITING | Glomerulonephritis; Immunoglobulin A Nephropathy |
Fondazione Schena |
2023-05-01 | PHASE4 |
| NCT07145788 | COMPLETED | Fibromyalgia (FM); Chronic Pain |
University Hospital Tuebingen |
2026-02-10 | |
| NCT06607861 | COMPLETED | Pain Score (VAS) |
Minia University |
2024-06-01 | EARLY_PHASE1 |
| NCT07521150 | ACTIVE_NOT_RECRUITING | Melorheostosis |
Yeditepe University |
2026-04-18 | |
| NCT07223216 | ACTIVE_NOT_RECRUITING | Obesity |
Biomea Fusion Inc. |
2025-10-23 | PHASE1 |
| NCT07021690 | NOT_YET_RECRUITING | Type 1 Diabetes (T1D) |
Steno Diabetes Center Copenhagen |
2025-06-30 | |
| NCT05864716 | UNKNOWN | Effect of Drug |
National Cheng-Kung University Hospital |
2024-10-01 | |
| NCT07089732 | NOT_YET_RECRUITING | Obesity; Prediabetes |
Chung Shan Medical University |
2025-08-08 | |
| NCT06933862 | NOT_YET_RECRUITING | Malnourished Children |
Indonesia University |
2025-05-15 | |
| NCT07207291 | RECRUITING | Bacterial Infections; Urinary Tract Infections; Intra-Abdominal Infections; Respiratory Tract Infections |
Joincare Pharmaceutical Group Industry Co., Ltd |
2025-08-22 | PHASE1 |
| NCT05775198 | RECRUITING | Infertility, Female; IVF |
Nadezhda Women's Health Hospital |
2023-03-01 | |
| NCT06863571 | RECRUITING | Ischemic Stroke |
Second Affiliated Hospital, Zhejiang University, School of Medicine |
2025-04-12 | PHASE3 |
| NCT06700395 | RECRUITING | Multiple Myeloma |
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. |
2024-11-28 | PHASE1 |
| NCT07371286 | NOT_YET_RECRUITING | Alcohol Use Disorder; Supplementation; Intestinal Permeability |
Assistance Publique - Hôpitaux de Paris |
2026-02 | |
| NCT05873127 | COMPLETED | Feeding and Eating Disorders |
Shanghai Mental Health Center |
2023-01-01 | |
| NCT06126354 | WITHDRAWN | Insulin Resistance; Prediabetic State; Non-Alcoholic Fatty Liver Disease; Overweight and Obesity |
Columbia University |
2024-07-01 | PHASE1 |
| NCT04475666 | RECRUITING | Critical Illness; Nutrition Disorders |
King Abdullah International Medical Research Center |
2020-09-21 | |
| NCT03889912 | COMPLETED | Cutaneous Squamous Cell Carcinoma; Basal Cell Carcinoma |
Regeneron Pharmaceuticals |
2019-04-11 | PHASE1 |
| NCT07448766 | COMPLETED | Chronic Low-back Pain (cLBP) |
Cairo University |
2024-09-01 | |
| NCT05084053 | COMPLETED | Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP); Multifocal Motor Neuropathy (MMN) |
Takeda |
2022-01-19 | PHASE3 |
| NCT06145282 | ACTIVE_NOT_RECRUITING | Sickle Cell Disease |
National Heart, Lung, and Blood Institute (NHLBI) |
2023-12-28 | PHASE1; PHASE2 |
| NCT04572815 | ACTIVE_NOT_RECRUITING | Hematologic and Lymphocytic Disorder; Hematopoietic and Lymphoid System Neoplasm |
Fred Hutchinson Cancer Center |
2021-05-14 | PHASE2 |
| NCT07154979 | COMPLETED | Oliceridine |
Shiyou Wei |
2025-09-04 | |
| NCT06991426 | NOT_YET_RECRUITING | Copd; Athletes |
Federal University of São Paulo |
2025-07 | PHASE4 |
| NCT06968286 | COMPLETED | Periodontitis Stage II |
Suez Canal University |
2025-01-01 | |
| NCT02416388 | RECRUITING | Acute Myeloid Leukemia (AML) |
University Hospital, Angers |
2015-01 | PHASE2; PHASE3 |
| NCT06821867 | COMPLETED | Skin Hydration; Skin Elasticity |
Mastelli S.r.l |
2024-12-18 | |
| NCT05531279 | UNKNOWN | Severe Aplastic Anemia |
Institute of Hematology & Blood Diseases Hospital, China |
2022-06-05 | |
| NCT06668298 | NOT_YET_RECRUITING | Old Age |
Henan Provincial People's Hospital |
2024-11 | |
| NCT06368895 | UNKNOWN | Hepatic Encephalopathy; Dysbiosis |
Fondazione Policlinico Universitario Agostino Gemelli IRCCS |
2021-04-07 | PHASE1 |
| NCT03872479 | UNKNOWN | Leber Congenital Amaurosis 10; Inherited Retinal Dystrophies; Eye Diseases, Hereditary; Retinal Disease; Retinal Degeneration; Vision Disorders; Eye Disorders Congenital |
Editas Medicine, Inc. |
2019-09-26 | PHASE1; PHASE2 |
| NCT04263597 | COMPLETED | Hematopoietic Stem Cell Transplant |
Children's Hospital Medical Center, Cincinnati |
2020-08-26 | PHASE1; PHASE2 |
| NCT07548541 | COMPLETED | Anaerobic Performance; Cognitive Performance; Healthy Volunteers |
Inonu University |
2025-04-01 | |
| NCT06498843 | COMPLETED | Rhinitis; Sinusitis; Upper Respiratory Infections; Colds |
YSLab |
2025-03-18 | |
| NCT06751121 | COMPLETED | Helicobacter Pylori Infection; Helicobacter Pylori Infected Patients; Helicobacter Pylori Infected Subjects |
Daewoong Pharmaceutical Co. LTD. |
2024-02-06 | PHASE3 |
| NCT05400161 | COMPLETED | Postpartum Depression; Parenting; Parent-Child Relations; Child Development |
Children's Hospital of Philadelphia |
2022-11-18 | |
| NCT07174895 | COMPLETED | Osteoarthritis, Knee |
Idlib University |
2021-08-06 | |
| NCT05393505 | UNKNOWN | Neutropenic Fever |
The University of Hong Kong |
2022-10-24 | PHASE4 |
| NCT05247788 | COMPLETED | Alcohol Use |
Mark Fillmore |
2022-02-02 | |
| NCT03897244 | COMPLETED | Helicobacter Pylori Infection |
National Taiwan University Hospital |
2019-05-30 | PHASE4 |
| NCT06576479 | RECRUITING | Chronic Kidney Diseases; Protein-Energy Malnutrition |
NIN Institute |
2018-07-10 | |
| NCT06539910 | UNKNOWN | Knee Arthropathy; Anesthesia, Local |
Alexandria University |
2024-08 | PHASE4 |
| NCT05896813 | UNKNOWN | Newly Diagnosed Peripheral T-cell Lymphoma |
The First Affiliated Hospital with Nanjing Medical University |
2023-03-01 | |
| NCT05877911 | UNKNOWN | Epithelial Ovarian Cancer; Acute Kidney Injury Due to Circulatory Failure |
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University |
2023-05 | PHASE2 |
| NCT06154824 | COMPLETED | Histamine; Cowhage |
Aalborg University |
2023-12-15 | |
| NCT06377995 | UNKNOWN | Chronic Neck Pain |
Escola Superior de Tecnologia da Saúde do Porto |
2024-09 | |
| NCT05034029 | UNKNOWN | Osteoarthritis |
Guangzhou First People's Hospital |
2021-08-01 | |
| NCT05517213 | COMPLETED | Multiple Myeloma |
Affiliated Hospital to Academy of Military Medical Sciences |
2022-09-01 | |
| NCT04841434 | COMPLETED | CNS Lymphoma |
Charite University, Berlin, Germany |
2021-06-01 | PHASE1; PHASE2 |
| NCT06571188 | COMPLETED | Post Operative Pain |
Menoufia University |
2024-08-01 | |
| NCT06587503 | UNKNOWN | Ebola Virus Disease; COVID-19 |
University of Birmingham |
2024-10 | PHASE4 |
| NCT07119749 | COMPLETED | Muscle Soreness |
University of Birmingham |
2023-09-01 | |
| NCT03810404 | UNKNOWN | Supplementation; Sport |
Poznan University of Physical Education |
2018-12-20 | PHASE3 |
| NCT06583785 | UNKNOWN | Older Adults |
University of Reading |
2023-12-05 | |
| NCT05855551 | COMPLETED | Birth Weight; Small for Gestational Age at Delivery; Diet; Deficiency; Gestational Weight Gain |
International Food Policy Research Institute |
2023-05-25 | |
| NCT05212688 | COMPLETED | COVID-19 |
Royal Marsden NHS Foundation Trust |
2022-07-19 | PHASE2 |
| NCT05764824 | COMPLETED | Cognitive Decline; Nutrition, Healthy; Brain Injuries |
Brigham and Women's Hospital |
2023-10-01 | |
| NCT07194577 | COMPLETED | Nutritional and Metabolic Diseases; Metabolic Syndrome |
Universidad de Colima |
2023-01-05 | |
| NCT05564039 | COMPLETED | Type 2 Diabetes |
Eli Lilly and Company |
2022-11-30 | PHASE4 |
| NCT05497739 | UNKNOWN | Gastric Cancer |
Cancer Institute and Hospital, Chinese Academy of Medical Sciences |
2022-06-28 | PHASE2 |
| NCT06351917 | COMPLETED | Knee Joint Pain |
RDC Clinical Pty Ltd |
2024-04-24 | PHASE4 |
| NCT07041866 | COMPLETED | This Study Aimed to Evaluate the Impact of Fortified Biscuit Consumption on the Iron Status of School-aged Children in Rural Kaolack |
Universite du Sine Saloum Elhadj Ibrahima Niasse |
2024-02-15 | |
| NCT06064279 | WITHDRAWN | Stage IV NSCLC |
VA Office of Research and Development |
2024-06-04 | PHASE1; PHASE2 |
| NCT05980494 | COMPLETED | Sepsis; Critical Illness |
Fayoum University Hospital |
2022-09-13 | |
| NCT05828758 | UNKNOWN | Enteral Feeding Intolerance |
Sohag University |
2023-04-24 | PHASE2; PHASE3 |
| NCT03950778 | COMPLETED | Albumin Supplementation; Albumin Therapy; Sepsis |
University of Pecs |
2023-03-04 | EARLY_PHASE1 |
| NCT05983562 | UNKNOWN | Diabetes Mellitus, Type 2; Hyperglycemia; Ketosis |
University of British Columbia |
2023-06-26 | |
| NCT07233460 | COMPLETED | Type 2 Diabetes Mellitus; Symptoms and Signs; Patient |
Hatice Demirağ, Ph.D |
2024-02-06 | |
| NCT06854666 | COMPLETED | Tennis Elbow; Lateral Epicondylitis; Lateral Epicondylitis (tennis Elbow); PRP Injection; PRP and Physiotherapy |
Rehasport Clinic |
2017-01-02 | |
| NCT05869526 | COMPLETED | Sarcopenia |
University of Glasgow |
2023-05-01 | |
| NCT06148974 | COMPLETED | Healthy |
Anne Nilsson |
2023-12-06 | |
| NCT05788497 | TERMINATED | Haemorrhoids Without Complication |
Faes Farma, S.A. |
2023-03-30 | PHASE3 |
| NCT06190860 | UNKNOWN | Alveolar Process Atrophy; Smoking, Cigarette; Platelet-Rich Fibrin |
Universidad de los Andes, Chile |
2022-05-29 | |
| NCT04129710 | UNKNOWN | Recurrent/RefractoryPrimary Central Nervous System Lymphoma (PCNSL) |
Second Affiliated Hospital, Zhejiang University, School of Medicine |
2020-01-01 | PHASE2 |
| NCT04794218 | UNKNOWN | Lassa Fever; Lassa Virus Infection |
International AIDS Vaccine Initiative |
2021-06-23 | PHASE1 |
| NCT03802461 | SUSPENDED | Infection |
Susy Hota |
2019-03-22 | PHASE2; PHASE3 |
| NCT04166773 | COMPLETED | Nonalcoholic Steatohepatitis |
Eli Lilly and Company |
2019-11-19 | PHASE2 |
| NCT04632992 | COMPLETED | Advanced Unresectable or Metastatic Solid Malignancy |
Genentech, Inc. |
2021-01-13 | PHASE2 |
| NCT05015348 | COMPLETED | Hyperlipidemias |
Peking Union Medical College Hospital |
2021-12-01 | |
| NCT04294979 | COMPLETED | Multiple Sclerosis |
IRCCS San Raffaele Roma |
2020-02-01 | |
| NCT05812664 | UNKNOWN | Enteral Feeding Intolerance |
Umraniye Education and Research Hospital |
2023-12 | |
| NCT06000436 | UNKNOWN | Cardiovascular Diseases |
Necmettin Erbakan University |
2023-11 | |
| NCT05764668 | UNKNOWN | Cough |
DoCare Pharmaceutial Technology Co.,Ltd |
2022-11-15 | PHASE3 |
| NCT04856800 | COMPLETED | Gestational Diabetes |
University of Aarhus |
2021-12-01 | |
| NCT06168773 | COMPLETED | Delirium in Old Age |
Ain Shams University |
2022-11-01 | PHASE2; PHASE3 |
| NCT03491540 | COMPLETED | Rectal Cancer Surgery |
Assistance Publique - Hôpitaux de Paris |
2018-09-03 | PHASE3 |
| NCT04514692 | TERMINATED | Cervix Cancer; Endometrial Cancer |
Stanford University |
2021-02-01 | PHASE1; PHASE2 |
| NCT05207488 | UNKNOWN | Overweight and Obesity |
University of Illinois at Urbana-Champaign |
2021-10-01 | |
| NCT04999358 | COMPLETED | Coronary Heart Disease; Low Protein Intake; Sarcopenia |
Northumbria University |
2021-11-29 | |
| NCT07237113 | COMPLETED | Damage Muscle |
Instituto de Ciencias de la Salud, Universidad de O'Higgins |
2021-09-01 | |
| NCT05256017 | COMPLETED | Trypanosomiasis, African; Trypanosoma Brucei Gambiense; Infection; Sleeping Sickness |
Drugs for Neglected Diseases |
2021-12-30 | PHASE2; PHASE3 |
| NCT05419674 | UNKNOWN | Helicobacter Pylori Infection |
Second Affiliated Hospital, Zhejiang University, School of Medicine |
2022-08-01 | PHASE4 |
| NCT01236560 | COMPLETED | Brain Stem Glioma; Cerebral Astrocytoma; Childhood Cerebellar Anaplastic Astrocytoma; Childhood Cerebral Anaplastic Astrocytoma; Childhood Spinal Cord Neoplasm |
National Cancer Institute (NCI) |
2011-01-26 | PHASE2; PHASE3 |
| NCT04341636 | COMPLETED | Periodontal Diseases; Dental Caries |
King Abdulaziz University |
2023-05-15 | |
| NCT05095038 | TERMINATED | Overweight and Obesity; PreDiabetes |
University of Copenhagen |
2022-02-10 | |
| NCT04976023 | COMPLETED | Allergic Rhinitis |
Prof. Lin Zhixiu |
2022-04-12 | PHASE2 |
| NCT05541003 | COMPLETED | Prader-Willi Syndrome; Obesity |
Rutgers, The State University of New Jersey |
2023-01-06 | PHASE2 |
| NCT05515614 | COMPLETED | Premature Birth; Breastmilk Collection; Postnatal Growth Restriction |
Loma Linda University |
2022-08-17 | |
| NCT04769687 | UNKNOWN | Chronic Renal Failure; Diabete Type 2; Systemic Inflammation |
Centre Hospitalier Universitaire de Besancon |
2020-11-21 | PHASE2 |
| NCT06393621 | COMPLETED | Prehypertension |
National Chung Hsing University |
2018-07-26 | |
| NCT05728424 | UNKNOWN | Helicobacter Pylori Infection |
Aga Khan University |
2022-09-20 | PHASE3 |
| NCT05328583 | UNKNOWN | Human Immunodeficiency Virus-1 (HIV-1) Infection |
RetroLead (Shanghai) BioPharma Co., Ltd. |
2022-04-15 | PHASE1 |
| NCT05658900 | UNKNOWN | Jaw Cysts |
Hams Hamed Abdelrahman |
2022-05-19 | |
| NCT05102162 | TERMINATED | Pneumonia |
University of Florida |
2021-12-17 | PHASE4 |
| NCT05018923 | UNKNOWN | Helicobacter Pylori Infection |
Shanghai Zhongshan Hospital |
2021-08-24 | PHASE4 |
| NCT05700851 | COMPLETED | Chronic Kidney Disease Requiring Chronic Dialysis |
University of Nottingham |
2022-09-27 | |
| NCT03719664 | UNKNOWN | HIV-1-infection |
Frontier Biotechnologies Inc. |
2018-12-17 | PHASE2 |
| NCT05318495 | UNKNOWN | Adenoma; Colo-rectal Cancer |
Dr. Horst Schmidt Klinik GmbH |
2022-03-01 | |
| NCT03871491 | COMPLETED | Maternal Death; Maternal Infections Affecting Fetus or Newborn; Neonatal SEPSIS; Maternal Sepsis During Labor; Neonatal Death; Postpartum Sepsis |
NICHD Global Network for Women's and Children's Health |
2020-09-01 | PHASE3 |
| NCT04753580 | COMPLETED | Healthy Volunteers; Frail Volunteers |
University Hospital, Clermont-Ferrand |
2021-10-04 | |
| NCT03164967 | COMPLETED | Humoral Immune Response |
ADMA Biologics, Inc. |
2016-12-29 | PHASE4 |
| NCT05507801 | COMPLETED | Appetitive Behavior; Gastric Emptying; Physical Activity; Energy Intake |
University of Reading |
2021-11-19 | |
| NCT04064528 | COMPLETED | Aging |
Purdue University |
2019-09-06 | |
| NCT04871971 | COMPLETED | Healthy |
Oxford Brookes University |
2021-09-15 | |
| NCT04755530 | COMPLETED | Overweight or Obesity; Metabolic Syndrome |
Faidon Magkos |
2021-02-25 | |
| NCT05457400 | COMPLETED | Sugar; Blood, Low |
Alpha Republic GmbH |
2022-04-28 | PHASE1 |
| NCT04165239 | COMPLETED | Mitochondrial Diseases; Mitochondrial Myopathies; Mitochondrial Encephalomyopathies; MELAS Syndrome; MIDD |
Khondrion BV |
2019-10-30 | PHASE2 |
| NCT05249374 | COMPLETED | Hepatic Ascites |
Beijing Protgen Biotechnology Development Co., Ltd. |
2021-10-14 | PHASE1 |
| NCT05292300 | COMPLETED | Insulin Resistance; Obesity; PreDiabetes |
Marmara University |
2021-05-24 | |
| NCT02461537 | COMPLETED | Acute Myeloid Leukemia |
DKMS gemeinnützige GmbH |
2015-09-17 | PHASE3 |
| NCT04540406 | COMPLETED | Suspected or Confirmed COVID-19 |
Notitia Biotechnologies Company |
2021-11-02 | PHASE2 |
| NCT05104762 | COMPLETED | Guillain-Barre Syndrome |
Assiut University |
2021-09-01 | PHASE2; PHASE3 |
| NCT05252962 | COMPLETED | Healthy |
Rousselot BVBA |
2021-11-26 | |
| NCT04902456 | UNKNOWN | Bimaxillary Protrusion |
Future University in Egypt |
2020-12-29 | |
| NCT04095520 | COMPLETED | Dental Erosion |
Yuzuncu Yil University |
2019-09-01 | |
| NCT04791475 | COMPLETED | Brachial Plexus Block; Dexmedetomidine; Dexamethasone; Bupivacaine |
Tribhuvan University Teaching Hospital, Institute Of Medicine. |
2021-02-22 | |
| NCT04147767 | UNKNOWN | Hypercholesterolemia; Breast Cancer; Obesity |
University of Leeds |
2020-02-10 | |
| NCT03692507 | UNKNOWN | Major Abdominal/GI Surgery |
University of California, San Francisco |
2021-07-30 | |
| NCT03614221 | COMPLETED | Atopic Dermatitis |
Chang Gung Memorial Hospital |
2019-06-03 | PHASE2 |
| NCT04836013 | UNKNOWN | Diarrhea Caused by Drug; Abdominal Pain |
Università degli Studi dell'Insubria |
2021-05-13 | |
| NCT04773301 | COMPLETED | Hip Fractures |
Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León |
2021-02-13 | PHASE4 |
| NCT03801902 | COMPLETED | Locally Advanced Lung Non-Small Cell Carcinoma; Locally Recurrent Lung Non-Small Cell Carcinoma; Stage II Lung Cancer AJCC v8; Stage III Lung Cancer AJCC v8; Unresectable Lung Non-Small Cell Carcinoma |
National Cancer Institute (NCI) |
2019-10-28 | PHASE1 |
| NCT06236659 | COMPLETED | Diet; Food; Nutrition |
Rob Erskine |
2019-12-01 | |
| NCT05140928 | COMPLETED | Gastrointestinal Microbiome; Immunoglobulin A; Growth; Stunting, Nutritional |
Andalas University |
2020-08-20 | |
| NCT04865952 | COMPLETED | Wound Heal; Wound Surgical; Oral Soft Tissue Conditions; Hyaluronic Acid |
University of Roma La Sapienza |
2021-04-29 | |
| NCT06585319 | COMPLETED | COVID 19 |
Materno-Perinatal Hospital of the State of Mexico |
2020-02-01 | PHASE2; PHASE3 |
| NCT04769726 | COMPLETED | Intervention |
Diabetes Foundation, India |
2017-12-16 | |
| NCT04872530 | COMPLETED | Bioavailability of Amino Acids Following Oral Ingestion of Plant-Based Proteins in Young, Healthy Men |
University of Limerick |
2020-01-08 | |
| NCT05687409 | COMPLETED | Cirrhosis, Liver; Metagonimiasis |
First Affiliated Hospital of Zhejiang University |
2019-11-24 | PHASE4 |
| NCT04451330 | COMPLETED | Acne Vulgaris |
Galderma R&D |
2020-07-29 | PHASE4 |
| NCT03043183 | UNKNOWN | Nutrition Disorders |
The First Hospital of Jilin University |
2017-03-01 | |
| NCT04035330 | UNKNOWN | Necrotic Pulp |
Cairo University |
2019-09 | |
| NCT04969536 | COMPLETED | Healthy |
Montana State University |
2019-10-01 | |
| NCT04569786 | TERMINATED | Coronavirus Disease (COVID-19) |
Merck Sharp & Dohme LLC |
2020-10-29 | PHASE1 |
| NCT04107194 | UNKNOWN | Helicobacter Pylori Infection; Antibiotic Resistant Infection; Antibiotic Resistant Strain |
University of Bari |
2020-01-14 | PHASE3 |
| NCT04235426 | UNKNOWN | Carpal Tunnel |
Dalia Salah Saif |
2018-01-26 | PHASE1 |
| NCT04921579 | COMPLETED | Bimaxillary Protrusion |
Future University in Egypt |
2019-12-15 | |
| NCT03732807 | COMPLETED | Alopecia Areata |
Pfizer |
2018-12-03 | PHASE2; PHASE3 |
| NCT02142803 | ACTIVE_NOT_RECRUITING | Adult Glioblastoma; Endometrial Clear Cell Adenocarcinoma; Endometrial Serous Adenocarcinoma; Ovarian Clear Cell Cystadenocarcinoma; Ovarian Endometrioid Adenocarcinoma; Ovarian Mucinous Cystadenocarcinoma; Ovarian Serous Cystadenocarcinoma; Recurrent Fallopian Tube Carcinoma; Recurrent Malignant Uterine Corpus Neoplasm; Recurrent Ovarian Carcinoma; Recurrent Primary Peritoneal Carcinoma; Solid Neoplasm; Stage IIIA Fallopian Tube Cancer AJCC v7; Stage IIIA Ovarian Cancer AJCC v6 and v7; Stage IIIA Primary Peritoneal Cancer AJCC v7; Stage IIIB Fallopian Tube Cancer AJCC v7; Stage IIIB Ovarian Cancer AJCC v6 and v7; Stage IIIB Primary Peritoneal Cancer AJCC v7; Stage IIIC Fallopian Tube Cancer AJCC v7; Stage IIIC Ovarian Cancer AJCC v6 and v7; Stage IIIC Primary Peritoneal Cancer AJCC v7; Stage IV Fallopian Tube Cancer AJCC v6 and v7; Stage IV Ovarian Cancer AJCC v6 and v7; Stage IV Primary Peritoneal Cancer AJCC v7 |
National Cancer Institute (NCI) |
2014-05-20 | PHASE1 |
| NCT03568643 | COMPLETED | Uncomplicated Severe Acute Malnutrition |
University of California, San Francisco |
2020-06-03 | PHASE3 |
| NCT04468958 | COMPLETED | COVID-19; SARS-CoV2 |
SAb Biotherapeutics, Inc. |
2020-07-01 | PHASE1 |
| NCT02991937 | COMPLETED | Appendicitis |
NYU Langone Health |
2016-12 | PHASE4 |
| NCT03802318 | UNKNOWN | Helicobacter Pylori Infection; Helicobacter Gastritis; Helicobacter-Associated Pyloric Ulcer |
Chang Gung Memorial Hospital |
2019-01-02 | |
| NCT04360122 | UNKNOWN | Coronavirus Disease (COVID-19) |
Ain Shams University |
2020-05-20 | PHASE3 |
| NCT04042077 | TERMINATED | Surgical Site Infection |
Menarini Group |
2019-09-25 | PHASE3 |
| NCT04444388 | COMPLETED | Healthy Athletes |
Universidad Europea de Madrid |
2020-07-01 | |
| NCT02283905 | TERMINATED | Blastomycosis |
University of Manitoba |
2015-06 | PHASE4 |
| NCT03850535 | TERMINATED | Acute Myeloid Leukemia |
Hoffmann-La Roche |
2019-03-25 | PHASE1; PHASE2 |
| NCT03639142 | UNKNOWN | Functional Constipation |
Medical University of Warsaw |
2018-09-01 | PHASE3 |
| NCT02942277 | COMPLETED | Malaria |
National Institute of Allergy and Infectious Diseases (NIAID) |
2016-10-21 | PHASE1 |
| NCT03681054 | ACTIVE_NOT_RECRUITING | Diabetes, Gestational; Dietary Modification; Glucose Intolerance During Pregnancy; Body Composition; Birth Weight |
Helsinki University Central Hospital |
2018-12-03 | |
| NCT03172676 | UNKNOWN | Immune Thrombocytopenia |
Assiut University |
2020-01-01 | PHASE4 |
| NCT02904772 | WITHDRAWN | LPL Deficiency |
UniQure Biopharma B.V. |
2016-10 | PHASE2 |
| NCT03535480 | UNKNOWN | Premature Ovarian Failure (POF) |
Instituto de Investigacion Sanitaria La Fe |
2018-06 | PHASE4 |
| NCT04223349 | COMPLETED | Healthy |
Janssen Research & Development, LLC |
2020-01-10 | PHASE1 |
| NCT03272542 | COMPLETED | Obesity |
San Francisco Veterans Affairs Medical Center |
2017-11-21 | PHASE2 |
| NCT04051476 | COMPLETED | Thermogenesis by Different-dosage Ginger Flour Footbaths |
ARCIM Institute Academic Research in Complementary and Integrative Medicine |
2019-09-16 | |
| NCT03920059 | TERMINATED | Lupus Nephritis |
Chulalongkorn University |
2019-08-20 | PHASE4 |
| NCT02920008 | COMPLETED | Acute Myeloid Leukemia |
Astex Pharmaceuticals, Inc. |
2017-03-16 | PHASE3 |
| NCT03680911 | TERMINATED | Anosmia; Head Trauma |
University of Miami |
2018-10-12 | PHASE3 |
| NCT04738994 | COMPLETED | Cardiac Rehabilitation |
Fondazione Don Carlo Gnocchi ETS |
2018-05-25 | |
| NCT03622424 | COMPLETED | Overweight and Obesity; PreDiabetes; Type2 Diabetes |
Gelesis, Inc. |
2017-08-22 | |
| NCT03584802 | TERMINATED | Exacerbation of Idiopathic Pulmonary Fibrosis |
Assistance Publique - Hôpitaux de Paris |
2019-05-16 | |
| NCT00058422 | COMPLETED | Lymphoma |
Memorial Sloan Kettering Cancer Center |
2003-02-10 | PHASE2 |
| NCT03211156 | COMPLETED | Vaginitis Gardnerella |
National Institute of Allergy and Infectious Diseases (NIAID) |
2017-09-11 | PHASE2 |
| NCT03795792 | COMPLETED | Metabolic Syndrome |
Coordinación de Investigación en Salud, Mexico |
2018-05-06 | |
| NCT02174263 | WITHDRAWN | Graft Versus Host Disease |
Fred Hutchinson Cancer Center |
2016-02 | PHASE2 |
| NCT03694821 | TERMINATED | Osteoarthritis |
UConn Health |
2018-07-05 | PHASE4 |
| NCT03885804 | COMPLETED | Pain, Postoperative |
Ain Shams University |
2019-03-20 | EARLY_PHASE1 |
| NCT03789227 | COMPLETED | Pain, Chronic |
Mansoura University |
2018-07-01 | |
| NCT02835339 | COMPLETED | Preeclampsia |
Oregon Health and Science University |
2016-07-12 | PHASE4 |
| NCT00392327 | COMPLETED | Anaplastic Medulloblastoma; Medulloblastoma |
Children's Oncology Group |
2007-05-23 | PHASE3 |
| NCT02947867 | UNKNOWN | Ischaemic Central Retinal Vein Occlusion; Neovascular Glaucoma |
Gene Signal SAS |
2017-01 | PHASE2; PHASE3 |
| NCT03519165 | COMPLETED | Ovarian Cancer |
Tata Medical Center |
2016-06 | |
| NCT05335824 | COMPLETED | Class II Division 1 Malocclusion |
Damascus University |
2019-02-08 | |
| NCT03868683 | COMPLETED | Diabetes Mellitus, Type 2; Obesity; PreDiabetes |
Singapore Institute of Food and Biotechnology Innovation |
2018-08-20 | |
| NCT03315338 | COMPLETED | Healthy |
Corcept Therapeutics |
2017-09-15 | PHASE1 |
| NCT03190369 | COMPLETED | Osteoarthritis |
Genzyme, a Sanofi Company |
2017-08-21 | PHASE3 |
| NCT03499457 | UNKNOWN | Penicillin Allergy |
Clalit Health Services |
2018-06 | |
| NCT03697499 | COMPLETED | Cardiovascular System; Respiratory System; Oxidative Stress; Inflammation |
Fudan University |
2018-09-20 | |
| NCT03291249 | WITHDRAWN | NASH - Nonalcoholic Steatohepatitis; NAFLD; T2DM (Type 2 Diabetes Mellitus) |
Tiziana Life Sciences LTD |
2017-12-01 | PHASE2 |
| NCT00777244 | UNKNOWN | Adrenocortical Carcinoma |
University of Turin, Italy |
2008-04 | PHASE3 |
| NCT02561962 | COMPLETED | Multiple Myeloma |
Amgen |
2015-11-20 | PHASE1 |
| NCT03421262 | UNKNOWN | Gestational Diabetes |
Hospital Mutua de Terrassa |
2017-06-01 | |
| NCT05029297 | COMPLETED | Diabetic Neuropathy, Painful |
Arafarma Group, S.A. |
2010-11-04 | PHASE3 |
| NCT02839876 | COMPLETED | Osteoarthritis; Acetaminophen; Arthroplasty, Hip Replacement |
Duke University |
2017-03-14 | PHASE4 |
| NCT03131687 | COMPLETED | Type 2 Diabetes Mellitus |
Eli Lilly and Company |
2017-05-24 | PHASE2 |
| NCT02603822 | COMPLETED | Impaired Small Intestinal Permeability |
Mayo Clinic |
2015-08 | PHASE1 |
| NCT04997122 | COMPLETED | Healthy; Hypercholesterolemia |
Instituto de Ciencia y Tecnología de Alimentos y Nutrición |
2018-04-02 | |
| NCT03615651 | COMPLETED | Probiotics; Gut Microbiota; Emotional Stress; Magnetic Resonance Imaging |
Örebro University, Sweden |
2018-01-22 | |
| NCT03203824 | COMPLETED | Healthy |
Loma Linda University |
2017-09-05 | |
| NCT03134352 | COMPLETED | Eczema |
Zai Lab Pty. Ltd. |
2017-04-26 | PHASE2 |
| NCT03711682 | COMPLETED | Type 2 Diabetes Mellitus |
Universidad Dr. José Matías Delgado |
2018-03-01 | PHASE2; PHASE3 |
| NCT03216278 | COMPLETED | Healthy Subjects in Fasted and Fed State |
AstraZeneca |
2017-09-26 | PHASE1 |
| NCT02740231 | COMPLETED | Knee Osteoarthritis |
Bone Therapeutics S.A |
2016-02 | PHASE2; PHASE3 |
| NCT01079013 | UNKNOWN | Non Hodgkin Lymphoma; Hodgkin Lymphoma |
Sheba Medical Center |
2010-03 | PHASE2 |
| NCT01665092 | COMPLETED | Septic Shock |
University of Mississippi Medical Center |
2013-01 | PHASE2 |
| NCT03101124 | COMPLETED | Surgical Wound; Bleeding |
St. Olavs Hospital |
2017-05-01 | PHASE2 |
| NCT02575534 | WITHDRAWN | Arrhythmias |
Evan Adelstein, MD |
2015-10 | |
| NCT03370497 | COMPLETED | Obesity; Diabetes |
University of Bath |
2017-10-01 | |
| NCT02132481 | COMPLETED | Substance Use Disorder (SUD); Recovery |
Chestnut Health Systems |
2015-06 | |
| NCT02424734 | TERMINATED | Late-onset Sepsis |
Pfizer |
2015-08-04 | PHASE2 |
| NCT01696669 | COMPLETED | Ewing's Sarcoma |
Grupo Espanol de Investigacion en Sarcomas |
2010-03-30 | PHASE2 |
| NCT00970866 | COMPLETED | Anemia; Malnutrition; Stunting |
University of California, Davis |
2009-11 | |
| NCT02203955 | COMPLETED | Pouchitis |
Mayo Clinic |
2014-08 | PHASE1 |
| NCT03846843 | COMPLETED | Cirrhosis |
Ocera Therapeutics, Inc. |
2016-08-15 | PHASE1 |
| NCT02350777 | TERMINATED | Hematopoietic Stem Cell Transplant; Poor Marrow Graft Function |
Memorial Sloan Kettering Cancer Center |
2015-01-21 | PHASE2 |
| NCT03113240 | COMPLETED | Critical Illness; Enteral Nutrition; Intestinal Permeability |
Shahid Beheshti University |
2017-04-01 | PHASE3 |
| NCT02728089 | COMPLETED | Urinary Tract Infection (UTI); Complicated Urinary Tract Infection; Pyelonephritis; Uncomplicated Pyelonephritis |
Merck Sharp & Dohme LLC |
2016-04-14 | PHASE3 |
| NCT00793676 | COMPLETED | Asthma; COPD |
University Hospital, Strasbourg, France |
2008-09 | |
| NCT01619020 | COMPLETED | Healthy |
Fred Hutchinson Cancer Center |
2012-10 | |
| NCT02449746 | COMPLETED | Schizophrenia; Psychosis; Auto Immune Disorders |
University of Cambridge |
2015-08 | |
| NCT03336853 | COMPLETED | Blood Contamination of Root Canal During Endodontic Therapy |
Dr Riccardo Pace |
2017-04-01 | |
| NCT01824940 | COMPLETED | Growth; Stunting, Nutritional; Anemia |
Johns Hopkins Bloomberg School of Public Health |
2012-11 | |
| NCT01033188 | COMPLETED | Knee Outcome, Subjective |
Oslo University Hospital |
2010-01 | |
| NCT02286219 | COMPLETED | Solid Tumors That Overexpress HER2 (HER2 Positive) |
Bristol-Myers Squibb |
2014-11-04 | PHASE1 |
| NCT01692197 | COMPLETED | Leukemia |
M.D. Anderson Cancer Center |
2013-02-01 | PHASE2 |
| NCT03105960 | UNKNOWN | Gingival Bleeding |
Cairo University |
2017-03-10 | |
| NCT02459535 | COMPLETED | Pre-diabetes; Diabetes |
German Institute of Human Nutrition |
2015-03 | |
| NCT02961972 | COMPLETED | Endothelial Dysfunction; Hyperhomocysteinemia |
National Institute of Cardiology, Laranjeiras, Brazil |
2015-01 | |
| NCT02682680 | COMPLETED | Type 2 Diabetes Mellitus |
LMC Diabetes & Endocrinology Ltd. |
2016-01-11 | PHASE4 |
| NCT02199041 | TERMINATED | Hematological Malignancies |
St. Jude Children's Research Hospital |
2014-07-11 | PHASE2 |
| NCT03586245 | COMPLETED | Iron Absorption |
Iowa State University |
2016-10-28 | |
| NCT03167918 | COMPLETED | Type 2 Diabetes Mellitus; Pulmonary Function |
Liaoning University of Traditional Chinese Medicine |
2014-07-21 | PHASE2; PHASE3 |
| NCT03294538 | COMPLETED | Atrophic Vaginitis |
Actavis Inc. |
2016-05-18 | PHASE3 |
| NCT02005419 | COMPLETED | Stage IA Pancreatic Adenocarcinoma; Stage IB Pancreatic Adenocarcinoma; Stage IIA Pancreatic Adenocarcinoma; Stage IIB Pancreatic Adenocarcinoma |
Xian-Jun Yu |
2013-12 | PHASE2 |
| NCT02337855 | COMPLETED | Schistosomiasis |
National Institute of Allergy and Infectious Diseases (NIAID) |
2015-02-04 | PHASE1 |
| NCT02333058 | COMPLETED | Acute Lymphoblastic Leukaemias (ALL); Acute Myeloid Leukaemias (AML); Myelodysplastic Syndromes (MDS); Juvenile Myelomonocytic Leukaemias (JMML) |
medac GmbH |
2014-11-21 | PHASE2 |
| NCT02679222 | COMPLETED | Healthy Adults |
Université de Sherbrooke |
2015-06 | |
| NCT02847286 | COMPLETED | HIV- Prevention |
International Partnership for Microbicides, Inc. |
2015-09-01 | PHASE1 |
| NCT03416504 | COMPLETED | Obsessive-Compulsive Disorder |
University of North Carolina, Chapel Hill |
2015-09-22 | |
| NCT02734901 | COMPLETED | Healthy |
Heinrich-Heine University, Duesseldorf |
2016-03 | |
| NCT02279420 | COMPLETED | Obesity |
USGI Medical |
2015-01-05 | |
| NCT02459834 | COMPLETED | Type 2 Diabetes |
University of Toronto |
2015-11 | |
| NCT02666287 | COMPLETED | Pulmonary Disease, Chronic Obstructive |
GlaxoSmithKline |
2016-01-27 | PHASE1 |
| NCT02312492 | COMPLETED | Dyslipidemia |
Tufts University |
2013-01 | |
| NCT02116322 | TERMINATED | Pancreatic Cancer |
Johns Hopkins University |
2014-04 | |
| NCT03057535 | COMPLETED | Pulmonary Ventilation |
McGill University |
2015-05 | EARLY_PHASE1 |
| NCT03783845 | COMPLETED | Chronic Periodontitis, Generalized |
Taibah University |
2015-06-01 | PHASE4 |
| NCT02317549 | TERMINATED | Septic Shock |
Leading BioSciences, Inc |
2015-04 | PHASE2 |
| NCT01746303 | COMPLETED | Age-related Memory Disorders; Mood Disorders |
University of Cincinnati |
2010-01 | |
| NCT03528707 | COMPLETED | Type2 Diabetes; NAFLD; Probiotic; Omega-3 Fatty Acids |
Bogomolets National Medical University |
2015-04-14 | |
| NCT03655041 | COMPLETED | Sports Nutritional Physiological Phenomena |
University of Sao Paulo |
2013-02-01 | |
| NCT01537055 | UNKNOWN | Eradication Rate for Helicobacter |
National Taiwan University Hospital |
2012-02 | PHASE4 |
| NCT01208714 | UNKNOWN | Renal Artery Stenosis |
University Hospital Padova |
2010-12 | PHASE4 |
| NCT02533986 | COMPLETED | Healthy |
Lund University |
2015-08 | PHASE1; PHASE2 |
| NCT02130817 | WITHDRAWN | End Stage Renal Disease; Antibody Mediated Rejection |
University of Wisconsin, Madison |
2014-09-24 | PHASE4 |
| NCT02559141 | COMPLETED | Perioperative/Postoperative Complications; C.Surgical Procedure; Digestive System |
University Hospital Schleswig-Holstein |
2014-03 | |
| NCT02498782 | UNKNOWN | Chagas Disease; Trypanosomiasis, South American; South American Trypanosomiasis; Disease, Chagas |
Drugs for Neglected Diseases |
2014-07 | PHASE2 |
| NCT02098486 | COMPLETED | Cholangitis |
Kangbuk Samsung Hospital |
2014-03 | PHASE2 |
| NCT01661985 | UNKNOWN | Urethritis; Cervicitis; Genital Mycoplasma Infection; Chlamydia Trachomatis |
Ostergotland County Council, Sweden |
2010-02 | PHASE4 |
| NCT03956433 | COMPLETED | Metabolic Syndrome |
University of Leeds |
2014-09-01 | |
| NCT00450801 | COMPLETED | Lymphoma |
University of Miami |
2004-04 | PHASE2 |
| NCT03263104 | COMPLETED | Healthy |
University of Roehampton |
2015-01 | |
| NCT01186224 | COMPLETED | Multiple Myeloma; Plasma Cell Dyscrasia; Lymphoma; Lymphoproliferative Disorders |
University of Liverpool |
2010-05 | |
| NCT02416258 | COMPLETED | Skin and Connective Tissue Diseases |
LEO Pharma |
2015-04 | PHASE2 |
| NCT02423980 | COMPLETED | Hypoglycemia |
Xeris Pharmaceuticals |
2015-04 | PHASE2 |
| NCT02710513 | COMPLETED | Healthy |
Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari |
2014-12 | |
| NCT02899507 | COMPLETED | Out-of-hospital Cardiac Arrest |
University Medical Centre Ljubljana |
2013-09 | PHASE4 |
| NCT01143545 | TERMINATED | Lung Cancer; Esophageal Cancer; Malignant Pleural Mesothelioma; Sarcoma; Thymic Carcinoma |
National Cancer Institute (NCI) |
2010-12-07 | PHASE1 |
| NCT03108287 | COMPLETED | Helicobacter Pylori Infection |
Kaohsiung Medical University Chung-Ho Memorial Hospital |
2013-04-01 | PHASE4 |
| NCT01343277 | COMPLETED | Advanced Liposarcoma or Leiomyosarcoma |
Janssen Research & Development, LLC |
2011-06 | PHASE3 |
| NCT01045460 | COMPLETED | Multiple Myeloma |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2010-01-15 | PHASE2 |
| NCT02224040 | UNKNOWN | Typhoid Fever |
Sheba Medical Center |
2013-08 | PHASE4 |
| NCT00253786 | COMPLETED | Type 2 Diabetes Mellitus; Diabetic Nephropathy |
Okayama University |
2005-11-11 | |
| NCT01594424 | COMPLETED | End Stage Renal Disease (ESRD) |
Cedars-Sinai Medical Center |
2012-06 | PHASE1; PHASE2 |
| NCT02414061 | COMPLETED | Healthy |
Northumbria University |
2014-04 | |
| NCT01502202 | UNKNOWN | Non Small Cell Lung Cancer; Adenocarcinoma |
National Cancer Center, Korea |
2012-03 | PHASE2 |
| NCT02108535 | COMPLETED | Second-degree Burn |
University of Sorocaba |
2013-11 | PHASE4 |
| NCT01548534 | TERMINATED | Metastatic Breast Cancer; Progesterone Receptor Positive Tumor; Estrogen Receptor Positive Tumor; HER-2 Negative Tumor |
University Hospital, Tours |
2012-02 | PHASE3 |
| NCT00914888 | WITHDRAWN | Community Acquired Bacterial Pneumonia; Complicated Intra-Abdominal Infection |
Wyeth is now a wholly owned subsidiary of Pfizer |
2011-01 | PHASE3 |
| NCT03589274 | COMPLETED | Alcohol Use Disorder |
Rutgers, The State University of New Jersey |
2010-06-01 | |
| NCT01026987 | COMPLETED | Stem Cell Transplant Patients |
Washington University School of Medicine |
2010-04-29 | PHASE1 |
| NCT01570582 | UNKNOWN | Fallopian Tube Cancer; Ovarian Cancer; Primary Peritoneal Cancer |
Korean Gynecologic Oncology Group |
2010-03 | PHASE2 |
| NCT02535897 | COMPLETED | Muscle, Skeletal |
University of Nottingham |
2013-07 | PHASE1 |
| NCT01976572 | COMPLETED | Hyperphosphatemia; Chronic Kidney Disease |
Tanabe Pharma Corporation |
2013-10 | PHASE1 |
| NCT01502982 | COMPLETED | Diffuse Large B-Cell Lymphoma |
Nordic Lymphoma Group |
2004-11 | PHASE2 |
| NCT01772875 | WITHDRAWN | Catheter Related Infections |
National Multiple Sclerosis Center |
2013-01 | |
| NCT02255812 | COMPLETED | Exploratory Behavior |
University Hospital, Basel, Switzerland |
2013-03 | |
| NCT01605929 | WITHDRAWN | Anesthesia; Upper Extremity Injury |
Brigham and Women's Hospital |
2012-07 | |
| NCT01874574 | COMPLETED | Knee Osteoarthritis |
Thammasat University |
2011-01 | PHASE4 |
| NCT01896492 | COMPLETED | PCOS |
Woman's Health University Hospital, Egypt |
2011-01 | PHASE4 |
| NCT02974348 | COMPLETED | Drug Resistant Malaria Due to Plasmodium Falciparum |
University of Bamenda |
2013-01 | PHASE3 |
| NCT01114516 | COMPLETED | Cervical Insufficiency |
Northwestern University |
2010-03 | |
| NCT01219764 | COMPLETED | Helicobacter Infections |
American University of Beirut Medical Center |
2010-10 | PHASE4 |
| NCT00313716 | COMPLETED | Anemia; Traumatic Brain Injury |
Claudia Sue Robertson |
2006-04 | PHASE2; PHASE3 |
| NCT03212040 | COMPLETED | Breast Biopsy |
University Hospital Tuebingen |
2011-12-05 | |
| NCT01637493 | UNKNOWN | Neutropenia |
Hangzhou Jiuyuan Gene Engineering Co. Ltd., |
2012-02 | PHASE1 |
| NCT01723059 | UNKNOWN | Helicobacter Infection |
Dallas VA Medical Center |
2012-02 | |
| NCT01837199 | COMPLETED | Chronic Periodontitis; Smoking |
University of Guarulhos |
2011-07 | PHASE4 |
| NCT01843296 | COMPLETED | Lumbar Spine Disc Herniation |
Isfahan University of Medical Sciences |
2012-11 | PHASE4 |
| NCT01579786 | UNKNOWN | Post Operative Pain |
University of Padova |
2011-05 | |
| NCT00286182 | COMPLETED | Anemia |
Mathew S. Maurer |
2007-07 | PHASE2 |
| NCT01645124 | TERMINATED | Polycythemia Vera |
Consorzio Mario Negri Sud |
2008-05 | PHASE3 |
| NCT00287586 | COMPLETED | Hypogonadism; Atherosclerosis |
Brigham and Women's Hospital |
2004-09 | PHASE4 |
| NCT01043536 | COMPLETED | Glioblastoma |
Centre Georges Francois Leclerc |
2009-09 | PHASE1 |
| NCT01644539 | COMPLETED | Appetite Regulation |
UMC Utrecht |
2011-07 | |
| NCT00544778 | TERMINATED | Sarcoma |
City of Hope Medical Center |
2001-08 | PHASE2 |
| NCT01039103 | TERMINATED | Acute Exacerbation of Remitting Relapsing Multiple Sclerosis; Clinically Isolated Syndrome |
Lakefront Biotherapeutics NV |
2009-12 | PHASE2 |
| NCT02389452 | COMPLETED | Osteoarthritis |
Genzyme, a Sanofi Company |
2010-02 | PHASE4 |
| NCT01016262 | TERMINATED | Proctitis, Ulcerative |
Forest Laboratories |
2009-11-30 | PHASE3 |
| NCT00644150 | COMPLETED | HIV Infections; Gonorrhea; Chlamydia |
University of California, Los Angeles |
2007-04 | |
| NCT01402648 | COMPLETED | Adenocarcinoma of Colon Recurrent |
CM&D Pharma Limited |
2009-10 | PHASE1; PHASE2 |
| NCT00054236 | COMPLETED | Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases |
Case Comprehensive Cancer Center |
2002-05 | PHASE1 |
| NCT00511810 | COMPLETED | Major Depressive Disorder |
University of Cincinnati |
2007-08 | PHASE2; PHASE3 |
| NCT01456572 | COMPLETED | Endocrine System Diseases |
University Hospital, Basel, Switzerland |
2007-01 | PHASE1 |
| NCT00283400 | TERMINATED | Subarachnoid Hemorrhage |
Baylor College of Medicine |
2006-01 | |
| NCT01181700 | COMPLETED | Pharmacokinetics |
Pfizer |
2010-10 | PHASE1 |
| NCT01428401 | COMPLETED | Stroke; Hemorrhagic Transformation Due to Acute Stroke |
China Medical University Hospital |
2008-01 | PHASE2 |
| NCT00315133 | COMPLETED | Type 1 Diabetes Mellitus |
University of Sao Paulo |
2003-12 | PHASE1; PHASE2 |
| NCT00430677 | TERMINATED | Systemic Lupus Erythematosus |
Bristol-Myers Squibb |
2007-06 | PHASE2; PHASE3 |
| NCT01677611 | COMPLETED | Type 2 Diabetes |
Khoo Teck Puat Hospital |
2008-12 | PHASE1 |
| NCT00437684 | UNKNOWN | HIV Infections; Hepatitis C |
IRCCS San Raffaele |
2007-02 | PHASE3 |
| NCT00746811 | COMPLETED | Primary Hypercholesterolemia |
Provident Clinical Research |
2010-01 | PHASE4 |
| NCT00570960 | TERMINATED | Spontaneous Bacterial Peritonitis |
University of Virginia |
2007-06 | PHASE4 |
| NCT00438321 | TERMINATED | Metabolic Syndrome |
Massachusetts General Hospital |
2006-09 | PHASE1 |
| NCT01316016 | COMPLETED | Obesity |
Lund University |
2009-04 | |
| NCT00433381 | COMPLETED | Adult Glioblastoma; Adult Gliosarcoma; Recurrent Adult Brain Neoplasm |
National Cancer Institute (NCI) |
2007-03-01 | PHASE2 |
| NCT00718354 | COMPLETED | Gastric Cancer; Gastroesophageal Cancer |
Thrombosis Research Institute |
2008-07 | PHASE3 |
| NCT00862134 | TERMINATED | Non-Small Cell Lung Cancer |
Proacta, Incorporated |
2009-03 | PHASE2 |
| NCT01484457 | COMPLETED | Diabetes Mellitus, Type 1 |
Sansum Diabetes Research Institute |
2008-07 | EARLY_PHASE1 |
| NCT00442910 | COMPLETED | Healthy |
Starpharma Pty Ltd |
2007-07 | PHASE1 |
| NCT02624141 | TERMINATED | Anemia |
Hoffmann-La Roche |
2006-04 | PHASE4 |
| NCT01858090 | COMPLETED | Elective Caesarean Section Surgeries |
Baskent University |
2009-01 | PHASE3 |
| NCT01856205 | COMPLETED | Japanese Encephalitis |
University of Liverpool |
2009-05 | PHASE2 |
| NCT01005927 | COMPLETED | Osteoporosis |
Purdue University |
2009-01 | PHASE1; PHASE2 |
| NCT00825994 | COMPLETED | Depression |
Massachusetts General Hospital |
2008-11 | |
| NCT00694642 | COMPLETED | Coronary Artery Disease; Refractory Angina |
Pilar Jimenez Quevedo |
2008-05 | PHASE1; PHASE2 |
| NCT00377260 | COMPLETED | Acute Otitis Media |
University of Pittsburgh |
2006-11 | PHASE4 |
| NCT00661063 | UNKNOWN | Diabetic Neuropathy; Pain |
Irmandade da Santa Casa de Misericordia de Sao Paulo |
2008-04 | PHASE3 |
| NCT00850590 | COMPLETED | Incontinence |
Norgine |
2009-02 | PHASE1 |
| NCT00723502 | COMPLETED | Gram-Negative Bacterial Infections; Helicobacter Infections; Dyspepsia |
MerLion Pharmaceuticals GmbH |
2008-09 | PHASE2 |
| NCT00785330 | COMPLETED | Non-Hodgkin's Lymphoma |
Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH |
2004-04 | PHASE2 |
| NCT00875797 | TERMINATED | Critically Ill |
University Medical Centre Ljubljana |
2004-10 | PHASE4 |
| NCT01333787 | COMPLETED | Constipation |
Federal University of São Paulo |
2008-02 | PHASE4 |
| NCT01617811 | COMPLETED | Hepatectomy |
Sir Run Run Shaw Hospital |
2007-08 | |
| NCT00364845 | TERMINATED | Anemia; Chronic Kidney Disease |
Amgen |
2006-09 | PHASE3 |
| NCT00705900 | COMPLETED | Chronic Plaque Psoriasis |
NeoStrata Company, Inc. |
2007-01 | |
| NCT00280683 | COMPLETED | Asthma |
University of California, Davis |
2004-12 | PHASE2 |
| NCT00451646 | COMPLETED | Parenteral Nutrition |
Fresenius Kabi |
2007-10 | PHASE3 |
| NCT00461955 | COMPLETED | Multiple Myeloma |
University Hospital, Bordeaux |
2007-08 | PHASE2 |
| NCT01250080 | COMPLETED | Moderate to Severe Trauma, as Defined by an; Injury Severity Score (ISS) > 12 Points Were Included in the Study. |
Hospital Universitari Son Dureta |
2007-01 | |
| NCT00724750 | COMPLETED | Acute Wounds From Trauma; Dehiscence or Surgical Complications |
University of Chicago |
2006-07 | |
| NCT00990847 | COMPLETED | Moderate Acute Asthma |
PT Otsuka Indonesia |
2007-06 | PHASE3 |
| NCT00268788 | COMPLETED | Multifocal Motor Neuropathy |
University of Aarhus |
2005-08 | PHASE2 |
| NCT00529282 | TERMINATED | Fever; Neutropenia; Gram-positive Bacterial Infections; Pseudomonas Infection |
Basilea Pharmaceutica |
2007-10 | PHASE3 |
| NCT01012843 | COMPLETED | Anal Fistula |
Ankara University |
2005-09 | |
| NCT04555460 | COMPLETED | Cerebral Herniation |
Ege University |
2003-01-23 | |
| NCT00657124 | COMPLETED | Liver Disease |
Kochi University |
2007-04 | PHASE4 |
| NCT00337987 | COMPLETED | Peripheral T-Cell Lymphoma |
Yale University |
2005-11 | PHASE2 |
| NCT00769132 | COMPLETED | Hypercholesterolemia |
Merck Sharp & Dohme LLC |
2007-08-03 | PHASE1 |
| NCT02608060 | TERMINATED | Anemia |
Hoffmann-La Roche |
2006-09 | PHASE4 |
| NCT00456339 | TERMINATED | Obstructive Sleep Apnea Syndrome |
University of Chicago |
2006-07 | PHASE4 |
| NCT01005342 | COMPLETED | Hypoglycemia; Hyperglycemia |
Lund University |
2007-05 | |
| NCT00253955 | COMPLETED | Pneumonia |
Sanofi |
2003-06 | PHASE3 |
| NCT00146562 | COMPLETED | Breast Cancer; Stage I Breast Cancer; Stage II Breast Cancer |
Harold J. Burstein, MD, PhD |
2003-07 | PHASE2 |
| NCT00432484 | COMPLETED | Rheumatoid Arthritis |
Chinese University of Hong Kong |
2005-05 | PHASE2 |
| NCT01121471 | COMPLETED | Diabetes Mellitus |
Ohio State University |
2004-12 | |
| NCT00494949 | COMPLETED | Hypotension; Hypoxia |
Sangart |
2003-04 | PHASE1; PHASE2 |
| NCT00103610 | COMPLETED | Lymphoma, Non-Hodgkin |
Genzyme, a Sanofi Company |
2005-01 | PHASE3 |
| NCT00586014 | COMPLETED | Multiple Myeloma |
Duke University |
1997-05 | PHASE2 |
| NCT00005800 | COMPLETED | Breast Cancer |
H. Lee Moffitt Cancer Center and Research Institute |
1999-04 | PHASE2 |
| NCT00039481 | COMPLETED | Cardiac Toxicity; Unspecified Childhood Solid Tumor, Protocol Specific |
National Cancer Institute (NCI) |
2002-11 | PHASE1 |
| NCT00395967 | TERMINATED | Multiple Myeloma; Lymphoma, Non-Hodgkin's |
Genzyme, a Sanofi Company |
2005-04 | PHASE2 |
| NCT01371175 | COMPLETED | HIV Infections |
International AIDS Vaccine Initiative |
2003-04 | PHASE2 |
| NCT00769418 | COMPLETED | Osteoporosis |
Merck Sharp & Dohme LLC |
2004-09 | PHASE1 |
| NCT00763997 | COMPLETED | Platelet Aggregation |
Ruhr University of Bochum |
2004-02 | |
| NCT00407342 | COMPLETED | Psoriasis |
Medical University of Graz |
2004-02 | |
| NCT00003691 | COMPLETED | Endometrial Cancer |
Gynecologic Oncology Group |
1998-12 | PHASE3 |
| NCT00005810 | COMPLETED | Prostate Cancer |
Alliance for Clinical Trials in Oncology |
2000-03 | PHASE2 |
| NCT00836901 | COMPLETED | Healthy |
Teva Pharmaceuticals USA |
2003-09 | PHASE1 |
| NCT00160264 | COMPLETED | Osteopenia |
Solvay Pharmaceuticals |
2003-01 | PHASE4 |
| NCT00422617 | COMPLETED | Chronic Plaque Psoriasis |
Uni-Pharma |
2005-01 | |
| NCT00006578 | WITHDRAWN | HIV Infections |
National Institute of Allergy and Infectious Diseases (NIAID) |
||
| NCT01020279 | COMPLETED | Musculoskeletal Pain |
X-pert Med GmbH |
2009-10 | PHASE1 |
| NCT01310361 | COMPLETED | Streptococcal Sore Throat |
Azad University of Medical Sciences |
2004-01 | PHASE1 |
| NCT00307879 | TERMINATED | Myocardial Infarction |
Seoul National University Hospital |
2004-03 | PHASE2 |
| NCT00643227 | COMPLETED | Pneumonia |
Pfizer |
2003-01 | PHASE3 |
(data from https://clinicaltrials.gov, updated on 2026-08-31)
Mechanism and Biochemical Profile
Appendix RUO and cGMP Quality Standards
| Quality Dimension | RUO (Research Use Only) | cGMP (Current Good Manufacturing Practice) |
|---|---|---|
| Clinical Applicability | Prohibited in human clinical trials or medical diagnostics. | Mandatory for human clinical trials (Phase I–III) and therapies. |
| Regulatory Status | Non-regulated grade; exempt from drug manufacturing laws. | Legally enforced by health authorities (e.g., FDA, EMA, NMPA). |
| Facility Environment | Unclassified analytical or research laboratories. | Validated Cleanrooms (ISO Class 5–8) with continuous monitoring. |
| Quality Control | Basic purity and activity testing. | Rigorous safety release testing (Sterility, Endotoxin, Mycoplasma). |
| Process Validation | Basic equipment calibration; no process validation required. | Full qualification (IQ/OQ/PQ) and complete batch records. |
| Quality Assurance | Vendor self-declared without required formal QMS. | Mandatory QA/QC unit, Change Control, CAPA, and vendor audits. |
| Regulatory Impact | High risk of IND rejection if used as a critical raw material. | Required for IND/NDA filings, supported by Drug Master Files (DMF). |
Footnotes
Regulatory Note: Governed by FDA (21 CFR Parts 210/211/312), EMA (EudraLex Vol 4), ICH Guidelines (E6/Q7/Q9/Q10), and compendial standards (USP <71>/<85>/<1043>).
- Pronase E (Activity ≥ 7000 U/g) Solubility in DMSO
- Pronase E (Activity ≥ 7000 U/g) Stock Solution
- Pronase E (Activity ≥ 7000 U/g) Storage
- Pronase E (Activity ≥ 7000 U/g) Stability
- Pronase E (Activity ≥ 7000 U/g) Molecular Weight
- Pronase E (Activity ≥ 7000 U/g) CAS Number
- Pronase E (Activity ≥ 7000 U/g) SDS|MSDS